Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)

NCT01470690 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

HCV Infections
Gastric Acid-related Disorders

Interventions

DRUG: boceprevir
DRUG: Omeprazole

Sponsor

Radboud University Medical Center

Collaborators

[object Object]